The Zotect study: Effect of zoledronic acid (Zometa®) on Bone Metabolism in Patients with Nreast or Prostate cancer with Bone metastases.

被引：0
|
作者：
Gschwendt, J. [1 ]
Ziller, M. [2 ]
Kalder, M. [2 ]
Lux, C. [1 ]
Maurer, T. [1 ]
Muth, M. [3 ]
Schmidt, K. [3 ]
Hadji, P. [2 ]
机构：
[1] Klinikum RD Isar, Urol Klin, Munich, Germany
[2] Univ Marburg, Marburg, Germany
[3] Novartis Pharma GmbH, BU Onkol, Nurnberg, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：204 / 204
页数：1
相关论文
共 50 条
  • [21] Zoledronic acid compared with pamidronate in patients with prostate cancer and bone metastases: Effects on skeletal complications and bone markers
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 57 - 57
  • [22] Zoledronic acid and atrial fibrillation in cancer patients with bone metastases
    Aksoy, S.
    Dizdar, O.
    Turgut, D.
    Dede, D. Sener
    Arslan, C.
    Harputluoglu, H.
    Altundag, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases
    Chen, TL
    Berenson, J
    Vescio, R
    Swift, R
    Gilchick, A
    Goodin, S
    LoRusso, P
    Ma, PM
    Ravera, C
    Deckert, F
    Schran, H
    Seaman, J
    Skerjanec, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11): : 1228 - 1236
  • [24] Zoledronic acid for the prevention of bone metastases in patients with breast cancer
    Coleman, R.
    Gralow, J.
    Bell, R.
    Lipton, A.
    EJC SUPPLEMENTS, 2004, 2 (03): : 74 - 75
  • [25] Evaluation of treatment patterns and costs for patients with prostate cancer and bone metastases.
    Valdarrama, Adriana
    Yao, Jianying
    Wen, Lonnie Kent
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [26] Bone metabolism biomarkers in men with advanced prostate cancer (PC) and bone metastases treated with denosumab versus zoledronic acid (ZA).
    Smith, Matthew Raymond
    Brown, Janet Elizabeth
    Fizazi, Karim
    Klotz, Laurence
    Marx, Gavin M.
    Wang, Huei
    Warner, Douglas
    Lipton, Allan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [27] Quality of life and pain among prostate cancer patients with bone metastases.
    Kurth, H
    McKiernan, J
    Bentkover, JD
    Thomas, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 439S - 439S
  • [28] Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer
    Weinfurt, KP
    Anstrom, KJ
    Castel, LD
    Schulman, KA
    Saad, F
    ANNALS OF ONCOLOGY, 2006, 17 (06) : 986 - 989
  • [29] Slow zoledronic acid releasing testis prostheses in the treatment of prostate cancer patients with bone metastases
    Serefoglu, Ege Can
    Balbay, M. Derya
    MEDICAL HYPOTHESES, 2009, 73 (03) : 387 - 388
  • [30] Use of zoledronic acid in patients with prostate cancer bone metastases: control of pain and musculoskeletal complications
    Paparella, Stefano
    Finkelberg, Elisabetta
    Varisco, Daniela
    Tondelli, Elena
    Rocco, Francesco
    UROLOGIA JOURNAL, 2011, 78 (04) : 300 - 304
12345